Measure Either Cholesterol Levels or Apoliproteins for CHD Risk (CME/CE)
Measurement of either cholesterol levels or apolipoproteins can suffice for assessing risk of coronary heart disease (CHD), analysis of data from a large prospective database found.
source : www.medpagetoday.com
Related News:
- HRT Linked to Asthma Risk (CME/CE)
- Older Women with Gout at Risk of MI (CME/CE)
- Exercise Program Associated With Denser Bones, Lower Fall Risk In Older Women
- Kaiser Study Compares Two AMD Treatments; "Eye Stroke" Prevalent Worldwide; New Data On Vision And Elders’ Risk Of Falling
- ICAO: Future Chronic Disease Risk Goes Beyond BMI (CME/CE)
- Immune Cells Point to Skin Cancer Risk after Transplants (CME/CE)
- ‘Silent Strokes’ Linked To Kidney Failure In Diabetics
- Immune Cell Levels Predict Skin Cancer Risk In Kidney Transplant Patients
- MRI Reveals Risk for Kidney Failure in Diabetic Patients (CME/CE)
- Low Vitamin D Levels May Raise Heart Disease Risk
Details :
Submited at Tuesday, November 10th, 2009 at 7:00 pm on Cardiology by chuck
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...
















